Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2021

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Secures $3.074M in Registered Direct Offering

Posted on January 13, 2021 by MissionIR

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced the closing of its previously disclosed registered direct offering of 3,650,840 shares of its common stock, at a purchase … Continue reading →

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Appears on C3 Chat Show Podcast

Posted on January 13, 2021 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP) chairman and CEO John Climaco was featured on a recent C3 Chat Show Podcast. The podcast, hosted by Sid Vaidya and Eric Gershey, explores topics related to entrepreneurship, life experiences and best practices. During his interview, Climaco … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Secures $5.1M in Underwritten Public Offering

Posted on January 13, 2021 by MissionIR

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial metal 3D printing industry, has announced the closing of its previously disclosed underwritten public offering of 1,488,507 shares of common stock, each at a public offering … Continue reading →

Posted in MissionIRNewsBreaks, Sigma Labs Inc. SGLB | Leave a comment

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Focuses on Multi-Omic Approach to Personalized Treatment Options

Posted on January 12, 2021 by MissionIR

Predictive Oncology (NASDAQ: POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery. The company is building a business around an emerging approach to disease prevention and treatment that … Continue reading →

Posted in Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX), First Wave, Receive Notice of Allowance for Niclosamide Patent

Posted on January 12, 2021 by MissionIR

AzurRx BioPharma (NASDAQ: AZRX), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, announced that it, along with First Wave Bio Inc., has received a notice of allowance from the United States Patent and … Continue reading →

Posted in AzurRx BioPharma Inc. AZRX, MissionIRNewsBreaks | Leave a comment

The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Positioned to Take Advantage of Growing Support, Legislative Changes

Posted on January 12, 2021 by MissionIR

Timing of expansion into CBD market correlated with passing of 2018 Farm Bill MORE Act decriminalizes marijuana, has passed the House Reclassification of cannabis by the UN may increase medical research, impact legalization efforts globally Founded in 2012, The Alkaline … Continue reading →

Posted in The Alkaline Water Company Inc. WTER | Leave a comment

MissionIRNewsBreaks – Loop Insights Inc. (TSXV: MTRX) (OTCQB: RACMF) Enters LOI with Leading European Digital Wallet and Mobile Marketing Company

Posted on January 12, 2021 by MissionIR

Loop Insights (TSXV: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick-and-mortar space, today announced its entry into a letter of intent (“LOI”) … Continue reading →

Posted in Loop Insights Inc. RACMF, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) Announces API Synthesis of Multiple Tryptamine Derivatives

Posted on January 12, 2021 by MissionIR

Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, is pleased to announce that Adelia Therapeutics Inc., a wholly-controlled subsidiary of Cybin, has achieved the earn-out milestones for the period commencing Nov. 15, 2020, as contemplated by … Continue reading →

Posted in Cybin Inc. CYBN, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Knightscope Inc. Expresses Gratitude to Investors

Posted on January 11, 2021 by MissionIR

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced that that it has over 18,000 investors! In the update, the company expressed its gratitude to its investors for their unwavering support through both … Continue reading →

Posted in Knightscope, Inc., MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at H.C. Wainwright BIOCONNECT 2021

Posted on January 11, 2021 by MissionIR

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, today announced that management will present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference. According … Continue reading →

Posted in MissionIRNewsBreaks, Processa Pharmaceuticals Inc. PCSA | Leave a comment